Pulse Biosciences

World Rank (Aug-2026)

4870

Market Cap (Aug-2026)

3.177 Billion USD

Market Cap (Mar-08-2026)

1.233 Billion USD

World Rank (Jan-05-2024)

11,984

Market Cap (Jan-05-2024)

0.555 Billion USD

World Rank (Jul-30-2023)

13,911

Market Cap (Jul-30-2023)

0.416 Billion USD

World Rank (Jan-07-2022)

14,855

Market Cap (Jan-07-2022)

0.400 Billion USD

World Rank (Jan-01-2021)

10,257

Market Cap (Jan-01-2021)

0.605 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

PLSE

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

0 Million USD

Annual Operating Income in USD

-77 Million USD

Annual Net Income in USD

-73 Million USD

Annual Results for Period Ending

For year ending December-2025

Total Assets in USD

95 Million USD

Total Liabilities in USD

14 Million USD

Total Equity in USD

81 Million USD

Balance Sheet for Period Ending

As of December-2025

Business Sector

Healthcare

Medical Equipment / Instruments

HealthCare Products

Company Website

PULSE BIOSCIENCES

Yahoo

Yahoo @ Nasdaq

Company Profile

Pulse Biosciences is a Novel Bioelectric Medicine company committed to health innovation that has the potential to improve and extend the lives of patients. It have 112 issued patents globally owned and licensed. The company annual revenue is 343.5 million USD and 82 employees as on 2020. The headquarters is in USA.

Founded Year

2014

IPO Year

2016

Stock Exchange

Nasdaq

Nasdaq Sector

Health Care

Nasdaq Industry

Medical/Dental Instruments